相关实验视频

Updated: Jan 18, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

肝酶中和单克隆抗体 (mAb A54) 减弱瘤生长和转移

Uri Barash¹, Malik Farhoud¹, Maali Odeh¹

¹Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel.

|September 13, 2025

概括

一种新型单克隆抗体 (mAb) 专门向并抑制肝酶,这是一种对癌症进展至关重要的酶. 这种抗体在临床前模型中显示出有希望,在与现有的癌症疗法相结合时,可以减少瘤生长和转移.

科学领域:

酶学是一种酶学.
癌症生物学癌症生物学
免疫学免疫学免疫学

背景情况:

肝酶是人类唯一降解肝硫酸盐 (HS) 的酶,重塑细胞外基质 (ECM) 并驱动癌症转移和血管生成.
肝酶通过释放HS结合的生长因子,促进瘤启动,血管化,生长,转移和化学抵抗.
现有的肝酶抑制剂缺乏特异性,并具有副作用,没有一个被批准用于临床使用.

研究的目的:

开发和描述一种新的,特定的肝酶酶活性抑制剂.
在临床前癌症模型中评估抗肝酶单克隆抗体 (A54 mAb) 的治疗潜力.

主要方法:

产生和表征抗肝酶单克隆抗体 (A54 mAb).
在体外测试测量肝酶酶活性和细胞吸收抑制.
在体内研究评估A54 mAb在骨髓瘤,质瘤,胰腺和乳腺癌的异种移植模型中的疗效,通常与常规药物结合使用.
A54 Fab片段与肝酶的联合结晶,以阐明结合机制.

主要成果:

A54 mAb 特别抑制肝酶酶的酶活性和细胞吸收.
在各种临床前癌症模型中,A54 mAb显著减弱瘤生长和转移.
与A54 mAb和常规抗癌药物的联合治疗显示出增强的疗效.
结构分析显示,A54 mAb在肝素硫酸盐结合域II附近结合,在固态上阻碍了酶基质相互作用.

结论:

一种新的单克隆抗体,A54 mAb,有效地中和肝酶酶的酶活性.
在临床前设置中,A54 mAb显示出抑制癌症进展和转移的显著潜力.
这种抗体代表了癌症和可能涉及肝酶活性的其他疾病的有希望的新疗法策略.

关键词:

组合疗法治疗组合治疗.肝硫酸盐是什么肝硫酸盐肝酶的使用方法中和单克隆抗体的抗体中和.胰腺癌是一种癌症.抑制瘤生长抑制瘤生长瘤异种移植瘤异种移植

更多相关视频

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.